HHS Issues Guidance on Substance Use Disorder Confidentiality Regulation

May 02, 2018 - 03:19 PM
Image of woman pointing to tablet and man reading it

The Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology and Substance Abuse and Mental Health Services Administration today released two factsheets to help health care providers and others apply the 42 CFR Part 2 regulations on confidentiality of substance use disorder patient records to health care programs and settings and the electronic exchange of health information. “SAMHSA works to connect people who have treatment needs to appropriate resources, and the opioid crisis has only increased the urgency with which we view this topic,” said HHS Assistant Secretary for Mental Health and Substance Use Elinore McCance-Katz. “We want to familiarize stakeholders with scenarios pertaining to Part 2 to help eradicate any barrier someone might encounter to either choosing or providing appropriate treatment.”

Related News Articles

Headline
FDA takes steps to spur OTC versions of naloxone
To encourage drug companies to seek approval for over-the-counter versions of naloxone, an emergency treatment for opioid overdose, the Food and Drug…
Headline
CDC: Rural patients more likely to receive opioid prescription
Patients in the most rural counties had an 87 percent greater chance of receiving an opioid prescription from their primary care provider between January 2014…
Headline
AHA Releases New Report that Shows Continued Rising Drug Prices and Drug Shortages are Disrupting Patient Care, Hospital Budgets
Continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and…
Perspective
Perspective: New Year, New Priorities
We’re 11 days into 2019 … we’ve returned to a divided government …and the partial government shutdown continues.
Headline
N.H. hospitals seek to intervene in psychiatric care lawsuit
The New Hampshire Hospital Association, along with hospitals across the state, recently filed a motion to intervene in a federal lawsuit filed against the…
Headline
CDC: Deaths from synthetic opioids continue to climb
U.S. overdose death rates linked to synthetic opioids increased more than 45 percent in 2017, likely driven by illicitly manufactured fentanyl, according to a…